-
Mashup Score: 0Examining Molecular Targets in Sarcoma - 6 month(s) ago
Mark Agulnik, MD, discusses advances in determining the molecular drivers of the tumor in the sarcoma space.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
TBI-1301 demonstrated superior efficacy compared with standard-of-care treatment in patients with synovial sarcoma. Further research is warranted.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ESMO Sarcoma and Rare Cancers Congress 2024: Registration - 7 month(s) ago
Registration is now open
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Registration now open for ESMO Sarcoma and Rare Cancers 2024. The scientific & educational programme will feature insights into diagnosis, prognostication, managemt & ongoing research. https://t.co/6V8Ggdarw8 #ESMOSarcomaAndRareCancers24 #scmsm #rarecancer @jeanyvesblay #sarcoma https://t.co/bEk00NtuaS
-
-
Mashup Score: 0
In August 2014, just a few weeks after my 15th birthday, my body began sending me a lot of worrisome signals that life as I knew it would soon be over. The year before, I had developed a hematoma in my right femur, which was resolved with surgery. But now the pain I was experiencing in that leg was even more i ntense than it had been the previous year, making it difficult to walk, and I was also having unexplained chronic fevers. Thinking the hematoma had recurred, my parents took me to see the surgeon
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Catalyzing Change Young Moroccan Oncologists Spearhead the Fight Against Sarcoma - The ASCO Post - 7 month(s) ago
The management of sarcoma presents several challenges because of its rarity and diverse subtypes, making accurate diagnosis and specialized treatment crucial. A multidisciplinary approach involving various experts from different cancer specialties is the optimal strategy to improve survival and reduce recurrence rates. Limited awareness and expertise in s arcoma among health-care professionals may lead to delayed or suboptimal management, emphasizing the importance of specialized sarcoma centers, particula
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HIV and Blood Cancers: New Insights | Dr. Antonio Giordano| SHRO - 7 month(s) ago
This blog was originally published in La Voce Di New York by Prof Antonio Giordano, click here to read in Italian. Recent research demonstrates that anti-retroviral (ARV) therapies to HIV patients prevent almost two-thirds of cancers, including Kaposi’s sarcoma and non-Hodgkin lymphoma, a cancer of the lymph nodes. These neoplastic diseases are frequently linked to patients with advanced AIDS or HIV-positive. This finding is very intriguing but larger studies are required to evaluate the use of
Source: www.drantoniogiordano.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial - 8 month(s) ago
Axitinib plus pembrolizumab has manageable toxicity and preliminary activity in patients with advanced sarcomas, particularly patients with ASPS, warranting further investigation in randomised controlled trials.
Source: www.thelancet.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Congrats to Dr. Sharon and colleagues for this important atezolizumab trial in a rare but immunoresponsive #sarcoma (ASPS) in @NEJM. Expands on findings led by @breelynwilkyMD and our group in Miami showing 70% PFS with combo axitinib/pembro. https://t.co/cF3vs3eJTm… https://t.co/6mt4UNW3UV https://t.co/mwdAG8BAc0
-
-
Mashup Score: 0Submitter Login Page - ACT 2024 Call for Abstracts - Advanced Cancer Therapies 2024 - 8 month(s) ago
This year, the 2024 Advanced Cancer Therapies (ACT) Meeting will be taking place February 16-19, 2024, in San Juan, Puerto Rico at the Condado Plaza Hilton. The Advanced Cancer Therapies Program Committee invite you to submit your abstracts with this online Call for Abstracts. The Committee encourages both SSO members, non-members and surgeons involved in cancer care to submit their scientific work and make this the best meeting yet! Advanced Cancer Therapies will serve as a comprehensive forum to
Source: www.abstractscorecard.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
The Kelly Turner Foundation is raising money for our research into Desmoplastic Small Round Cell Tumour – a particularly aggressive type of sarcoma
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Kelly Turner passed away in 2017, aged 17, from #DSRCT - an aggressive type of #Sarcoma that occurs mostly in adolescents and young people. Her parents set up a foundation in her memory, working tirelessly to fulfil her wish to improve #DSRCT treatments: https://t.co/3sjIXY2D0p https://t.co/0PxgkXQ76e
-
-
Mashup Score: 1SARC Talk Episode 10 - Dr. Roberta Sanfilippo - 8 month(s) ago
This episode of SARC Talk features Dr. Roberta Sanfilippo from Instituto Nazionale Tumori in Milan, Italy. Dr. Sanfilippo shares her insights on mentorship, …
Source: www.youtube.comCategories: Healthcare Professionals, Latest HeadlinesTweet
WATCH: Mark Agulnik, MD, discusses advances in determining the molecular drivers of the tumor in the #sarcoma space. @AgulnikMd @cityofhope https://t.co/ZtkKxZFuam